Cunning Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,945
Closed -$1.37M 78
2022
Q3
$1.37M Hold
15,945
1.09% 44
2022
Q2
$1.45M Sell
15,945
-3,205
-17% -$284K 1.12% 42
2022
Q1
$1.57M Buy
+19,150
New +$1.51M 1.08% 21

Other funds holding MRK

Cunning Capital Partners's MRK Position: Q4 2022 in Review

Cunning Capital Partners sold out of Merck (MRK) in Q4 2022, closing a stake of 15,945 shares — an estimated $1.37M sold.

Cunning Capital Partners first reported a position in MRK in Q1 2022 and held it in 3 quarters. The position peaked at $1.57M in Q1 2022. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Cunning Capital Partners reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • Cunning Capital Partners sold 15,945 Merck shares in Q4 2022, an estimated $1.37M.
  • Cunning Capital Partners first reported a position in Merck in Q1 2022 and held it in 3 quarters.
  • Cunning Capital Partners's Merck position peaked at $1.57M in Q1 2022.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Cunning Capital Partners's 13F filing for Q4 2022, filed 10 Feb 2023.